Lucidone A

CAS No. 97653-92-4

Lucidone A( ——— )

Catalog No. M38478 CAS No. 97653-92-4

Lucidone A is a lanostanoid isolated from the fruiting bodies of G. resinaceum. lucidone A showed inhibitory effects against the increase of ALT and AST levels in HepG2 cells induced by H2O2 compared to a control group in the range of their maximum non-toxic concentration (MNTC) .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote

Biological Information

  • Product Name
    Lucidone A
  • Note
    Research use only, not for human use.
  • Brief Description
    Lucidone A is a lanostanoid isolated from the fruiting bodies of G. resinaceum. lucidone A showed inhibitory effects against the increase of ALT and AST levels in HepG2 cells induced by H2O2 compared to a control group in the range of their maximum non-toxic concentration (MNTC) .
  • Description
    Lucidone A is a natural product from Ganoderma lucidum (Leyss. Ex Fr.) Karst.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    97653-92-4
  • Formula Weight
    402.52
  • Molecular Formula
    C24H34O5
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Peng XR,et al. Protective effects of triterpenoids from Ganoderma resinaceum on H?O?-induced toxicity in HepG2 cells. Food Chem. 2013 Nov 15;141(2):920-6.?
molnova catalog
related products
  • 8-Prenyldaidzein

    8-Prenyldaidzein is an isoflavonoid, that can be isolated from Bituminaria morisiana. 8-Prenyldaidzein shows antioxidant activity.

  • Antalarmin hydrochlo...

    CRF1 antagonist

  • SARS-CoV-2-IN-14

    SARS-CoV-2-IN-14 is a potent and oral inhibitor of SARS-CoV-2 (IC50:0.39 μM), which is an analogue of niclosamide.